FSB Sees Some Progress in OTC Reform

Progress has been made in setting and implementing international standards for over-the-counter (OTC) derivatives market reforms in a number of jurisdictions, according to the latest progress report by the Financial Stability Board (FSB).
Published every six months, the FSB report reviews progress made by international standard-setting bodies, national and regional authorities, and market participants toward getting all standardized OTC contracts to be traded on exchanges or electronic trading platforms and cleared through central counterparties (CCPs), having OTC derivative contracts be reported to trade repositories, and making non-centrally cleared contracts be subject to higher capital requirements.
The jurisdictions with the largest markets in OTC derivatives—the EU, Japan and the US—are the most advanced in structuring their legislative and regulatory frameworks, the report says. They expect to have regulatory frameworks in place by the end of 2012 and practical implementation within their markets is well under way. Other jurisdictions are generally less advanced. One reason is that some jurisdictions have been waiting for the key elements of the regulatory frameworks in the EU, Japan and the US to be finalized before putting their own legislation in place. Others have sought greater certainty about the application of international principles and safeguards to cross-border financial market infrastructure.
Based on its findings, the FSB recommends that market participants expand the number and scope of OTC derivatives transactions that are standardized, centrally cleared, traded on organized platforms and reported to trade repositories.
In the next progress report, to be published before the November G20 Finance Ministers and Central Bank Governors meeting, the FSB intends to put additional focus on the readiness of infrastructures to provide central clearing, platform trading and reporting of OTC derivatives, the practical ability of industry to meet the requirements, and the remaining steps for industry to take.
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe
You are currently unable to print this content. Please contact info@waterstechnology.com to find out more.
You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@waterstechnology.com
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@waterstechnology.com
More on Regulation
Nasdaq leads push to reform options regulatory fee
A proposed rule change would pare costs for traders, raise them for banks, and defund smaller venues.
The CAT declawed as Citadel’s case reaches end game
The SEC reduced the CAT’s capacity to collect information on investors, in a move that will have knock-on effects for its ongoing funding model case with Citadel.
Waters Wavelength Ep. 305: Cato Institute's Jennifer Schulp
Jennifer joins to discuss what regulatory priorities might look under Paul Atkin's SEC.
Examining Cboe’s lawsuit appealing SEC’s OEMS rule rejection
The Chicago-based exchange has sued the regulator in the Seventh Circuit Court of Appeals after the agency blocked a proposed rule that would change how Silexx is classified.
European exchange data prices surge, new study shows
The report analyzed market data prices and fee structures from 2017 to 2024 and found that fee schedules have increased exponentially. Several exchanges say the findings are misleading.
Regis-TR and the Emir Refit blame game
The reporting overhaul was been marred by problems at repositories, prompting calls to stagger future go-live dates.
FCA: Consolidated tape for UK equities won’t happen until 2028
At an event last week, the FCA proposed a new timeline for the CT, which received pushback from participants, according to sources.
Cusip Global Services wants to know, ‘What’s your damage?’
The evidence and discovery phase of the case against the identifier bureau is set to expire in March, bringing an anticipated jury trial one step closer.